Arcus Biosciences RCUS

$ 14.26 -2.46%

Quarterly report 2024-Q3
added 11-06-2024

Arcus Biosciences Financial Statements 2011-2024 | RCUS

Annual Financial Statements Arcus Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.21 B	1.31 B	2.58 B	1.93 B	399 M	329 M	-	-	-	-	-	-	-
Shares	74 M	72 M	69.3 M	54.8 M	43.8 M	34.6 M	-	-	-	-	-	-	-
Historical Prices	16.4	18.2	37.2	35.3	15.2	11.8	-	-	-	-	-	-	-
Net Income	-307 M	-267 M	53 M	-123 M	-84.7 M	-49.6 M	-53.1 M	-18 M	-	-	-	-	-
Revenue	117 M	112 M	383 M	78 M	15 M	8.35 M	1.41 M	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-340 M	-280 M	54 M	-124 M	-88.7 M	-54.9 M	-53.4 M	-18.2 M	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-332 M	-274 M	58 M	-121 M	-85.1 M	-51.2 M	-50.8 M	-16.9 M	-	-	-	-	-
Operating Expenses	457 M	392 M	329 M	202 M	104 M	63.2 M	-	-	-	-	-	-	-
General and Administrative Expenses	117 M	104 M	72 M	43 M	25.2 M	13.6 M	7.64 M	3.94 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Arcus Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	91.4 M	91.1 M	86.2 M	75.5 M	74.6 M	73.2 M	73 M	72.9 M	72.2 M	71.8 M	71.2 M	70.8 M	70.1 M	69.7 M	67.1 M	63.5 M	62.6 M	48.6 M	44.3 M	44.1 M	43.9 M	45.4 M	44.5 M	43.2 M	44.5 M	44.5 M	11.6 M	2.21 M	3.99 M	3.9 M	3.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-92 M	-93 M	-4 M	-	-71 M	-75 M	-80 M	-	-65 M	-67 M	-68 M	-	-78 M	-76 M	-72.6 M	-51.9 M	1.82 M	-45.1 M	-27.8 M	-16.6 M	-22.4 M	-28.1 M	-17.7 M	-12.3 M	-10.8 M	-13.5 M	-13 M	-13.2 M	-23.1 M	-9.55 M	-7.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	48 M	39 M	145 M	-	32 M	29 M	25 M	-	33 M	27 M	18 M	-	9.46 M	9.46 M	9.46 M	9.49 M	64.5 M	1.75 M	1.75 M	9.75 M	1.75 M	1.75 M	1.75 M	1.56 M	4.29 M	1.25 M	1.25 M	1.25 M	163 K	-141 K	-70 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-105 M	-106 M	-16 M	-	-80 M	-83 M	-86 M	-	-70 M	-69 M	-67 M	-	-78.1 M	-76.1 M	-72.7 M	-	1.55 M	-45.4 M	-28.4 M	-	-23.2 M	-29.2 M	-18.8 M	-	-12.1 M	-15.9 M	-13.3 M	-	-23.1 M	-9.66 M	-7.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-13 M	-	-	-	-84 M	-	-65.5 M	-69 M	-66 M	-	-75.6 M	-76.1 M	-71.9 M	-	3.92 M	-43.7 M	-27.6 M	-	-22.4 M	-28.4 M	-17.8 M	-	-11.2 M	-15 M	-12.5 M	-	-22.4 M	-9.06 M	-6.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	153 M	145 M	161 M	-	112 M	112 M	111 M	-	103 M	96 M	85 M	-	87.6 M	85.6 M	82.2 M	61.5 M	63 M	47.1 M	30.2 M	27.3 M	25 M	30.9 M	20.5 M	15 M	16.4 M	17.1 M	14.6 M	14.6 M	23.3 M	9.66 M	7.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	30 M	30 M	32 M	-	30 M	28 M	30 M	-	26 M	26 M	24 M	-	16.3 M	16.8 M	15.8 M	-	11.2 M	11.4 M	7.01 M	-	7.76 M	5.91 M	4.97 M	-	3.58 M	3.45 M	2.93 M	-	1.86 M	1.83 M	1.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency